Related Experiment Video
Updated: Mar 19, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
"Back to the Future": A New Look at Hydroxypropyl Beta-Cyclodextrins
Milo Malanga1, Julianna Szemán1, Éva Fenyvesi1
1CycloLab Cyclodextrin Research & Development Ltd, Budapest, Hungary H-1097.
(2-hydroxypropyl) beta-cyclodextrin (HPBCD) is a key drug formulation excipient. Its properties, including aggregation, toxicity, and drug solubilization, vary with the degree of substitution, impacting its application.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Analytical Chemistry
Background:
- (2-hydroxypropyl) beta-cyclodextrin (HPBCD) is a widely approved pharmaceutical excipient known for its solubilizing and stabilizing properties in oral and parenteral formulations.
- Recent findings highlight HPBCD's pharmacological activity across various diseases, necessitating a deeper understanding of its structure-activity relationship.
- HPBCD is a complex mixture of isomers with varying hydroxypropylation patterns, leading to differences among products from different manufacturers.
Purpose of the Study:
- To investigate the impact of the average degree of substitution of HPBCD on its aggregation behavior, toxicity, and drug solubilizing capabilities.
- To compare HPBCD products from different manufacturers using a comprehensive suite of analytical techniques.
- To establish structure-property correlations for HPBCD to optimize its use in pharmaceutical formulations.
Main Methods:
- Characterization of multiple HPBCD samples using thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), HPLC-mass spectrometry (MS), and matrix-assisted laser desorption MS.
- Assessment of HPBCD aggregation propensity based on the average degree of substitution.
- Evaluation of HPBCD toxicity using Caco-2 cell assays and hemolytic activity tests.
- Determination of HPBCD's solubilizing effect on poorly soluble drugs with varying properties.
Main Results:
- HPBCD products with a lower average degree of substitution exhibited a higher tendency for aggregation.
- All tested HPBCD samples demonstrated non-toxicity to Caco-2 cells and low hemolytic activity.
- The enhancement of solubility for poorly soluble drugs varied with the degree of substitution, showing either a decrease, an increase, or a maximum effect contingent on the drug's characteristics.
Conclusions:
- The average degree of substitution is a critical parameter influencing HPBCD's physical and functional properties.
- HPBCD exhibits a favorable safety profile, with low toxicity and hemolytic activity across the studied range of substitution.
- Understanding the structure-property relationship of HPBCD is essential for optimizing its performance as a solubilizer for diverse poorly soluble drugs.
Related Concept Videos
Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization
Stability of Substituted Cyclohexanes
The two chair conformations of cyclohexanes undergo rapid interconversion at room temperature. Both forms have identical energies and stabilities, each comprising equal amounts of the equilibrium mixture. Replacing a hydrogen atom with a functional group makes the two conformations energetically non-equivalent.
For example, in...
Preparation of Diols and Pinacol Rearrangement
The reaction begins with transferring a proton from the acid catalyst to one of the hydroxyl groups, producing an oxonium ion.
β-Dicarbonyl Compounds via Crossed Claisen Condensations
Chemistry of Carbohydrates
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.

